Replication Data for: Observations on clot structure and function in atrial fibrillation: relation to renal function and choice of anticoagulant
收藏NIAID Data Ecosystem2026-03-11 收录
相关数据集
Supplementary Material for: Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
Background: This study aimed to determine whether use of oral anticoagulants (OACs) was associated with a reduced risk of recurrent stroke compared with use of antiplatelets (APs) in pat
DataCite Commons2020-11-11 更新90
Proportion of patients with TTR <65% and ≥65% in different geographic regions.
Proportion of patients with TTR <65% and ≥65% in different geographic regions.
NIAID Data Ecosystem60
Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
Abstract Background: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atri
DataCite Commons2020-08-28 更新40
Additional file 7 of Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
Additional file 7: Figure S5A-B. Estimates of VTE recurrence and major bleeding risk between longer and shorter duration of anticoagulation in the subgroups. Note: A: During the anticoagulation B: Fro
DataCite Commons2024-02-15 更新70
Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants
Objective: To assess long-term healthcare costs related to ischemic stroke and systemic embolism (stroke/SE) and major bleeding (MB) events in patients with non-valvular atrial fibrillation (NV
DataCite Commons2022-10-14 更新60
